Aura Biosciences, Inc. Adjustments to Additional Paid in Capital, Other
Aura Biosciences, Inc. (AURA) reported Adjustments to Additional Paid in Capital, Other of $27.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-11-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-11-13
- Aura Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $27.00K.
- Aura Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-09-30 was $62.00K.
- Aura Biosciences, Inc. adjustments to additional paid in capital, other for fiscal 2022 was $62.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2025-03-31 | $27.00K 10-Q · filed 2025-11-13 | |
| 2022-12-31 | $62.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $62.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |